|Bid||37.64 x 800|
|Ask||37.73 x 1400|
|Day's Range||37.11 - 37.99|
|52 Week Range||32.21 - 49.14|
|Beta (5Y Monthly)||0.68|
|PE Ratio (TTM)||5.39|
|Forward Dividend & Yield||0.66 (1.74%)|
|Ex-Dividend Date||Oct 07, 2020|
|1y Target Est||N/A|
Ingles Markets, Incorporated (NASDAQ: IMKTA) has announced that the company will be partnering with the U.S. Department of Health and Human Services (HHS) to provide the administration of the coming COVID-19 vaccine. Ingles Pharmacies will receive direct allocations of COVID-19 vaccine once a vaccine is approved for its safety and efficacy and recommended for use in the United States.
Ingles Markets, Incorporated (NASDAQ: IMKTA) today announced that its Board of Directors has declared a cash dividend of $0.165 (sixteen and one-half cents) per share on all its Class A Common Stock and $0.15 (fifteen cents) per share on all its Class B Common Stock. This is an annual rate of $0.66 and $0.60 per share, respectively. Dividends on both the Class A and Class B Common Stock are payable October 15, 2020, to all shareholders of record on October 8, 2020.
Ingles Markets, Incorporated (NASDAQ: IMKTA) reports its most recent efforts to recognize and support associates during the COVID-19 crisis.